Lexeo Therapeutics Announces FDA Support for Accelerated Approval Pathway, Positive Interim Data for Gene Therapy LX2006

Lexeo Therapeutics Inc. (NASDAQ: LXEO) is one of the best young stocks with huge upside potential. On October 7, Lexeo ...